bempegaldesleukin

BMS and Nektar Shutter Combination Cancer Development Program
BioSpace
Fri, 04/15/22 - 01:42 pm
Bristol Myers Squibb
Nektar Therapeutics
bladder cancer
renal cell carcinoma
bempegaldesleukin
Nektar Left Reassessing After Canceled Melanoma Trials
BioSpace
Tue, 03/15/22 - 11:38 pm
Nektar
Bristol Myers Squibb
clinical trials
melanoma
bempegaldesleukin
BMS-Nektar's Opdivo combo fails phase 3 in upset to once-largest licensing deal in biotech history
Fierce Biotech
Mon, 03/14/22 - 10:24 am
Bristol Myers Squibb
Opdivo
Nektar Therapeutics
bempegaldesleukin
clinical trials
Propel fails to propel Nektar
EP Vantage
Mon, 11/8/21 - 10:48 am
Nektar Therapeutics
Merck
bempegaldesleukin
clinical trials
metastatic non-small cell lung cancer
Immuno-oncology combination for melanoma using Nektar drug boosts cell therapy in mice
Fierce Biotech
Fri, 01/31/20 - 12:11 pm
melanoma
Nektar Therapeutics
bempegaldesleukin